These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 194800)

  • 21. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
    Balla T; Baukal AJ; Eng S; Catt KJ
    Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
    Lin K; Chan SH; Chan JY
    Synapse; 2001 Apr; 40(1):85-94. PubMed ID: 11170225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiotensin II receptors in the adrenals].
    Porunkevich EA; Kublis GG; Skuin'sh AA
    Probl Endokrinol (Mosk); 1980; 26(6):74-83. PubMed ID: 6256730
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin II receptors of human and primate adrenal fasciculata and glomerulosa: correlations of binding and steroidogenesis.
    Douglas JG; Brown GP; White C
    Metabolism; 1984 Aug; 33(8):685-8. PubMed ID: 6087082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of aldosterone production by angiotensin II peptides in vitro: enhanced activity of the (1-sarcosine) analogue.
    Fredlund P; Saltman S; Catt KJ
    J Clin Endocrinol Metab; 1975 Apr; 40(4):746-9. PubMed ID: 1127086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of DES-ASP1-angiotensin II is not an obligatory step in the steroidogenic action of angiotensin II in the canine adrenal.
    Douglas J; Bartley P; Kondo T; Catt K
    Endocrinology; 1978 Jun; 102(6):1921-4. PubMed ID: 744059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-nephrectomy changes in adrenal angiotensin II receptors in the rat; influence of exogenous angiotensin and a competitive inhibitor.
    Pernollet MG; Devynck MA; Matthews PG; Meyer P
    Eur J Pharmacol; 1977 Jun; 43(4):361-72. PubMed ID: 195820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors regulating tachyphylaxis triggered by N-terminal-modified angiotensin II analogs.
    Barros AJ; Ito CM; Makino EN; Cembranelli FA; Moraes FC; Souza SE; Oliveira L; Shimuta SI; Nakaie CR
    Biol Chem; 2009 Dec; 390(12):1265-70. PubMed ID: 19804361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of specific angiotensin inhibitors in the study of hormone-receptor interaction].
    Myshlyakova NV; Indulen YuI ; Klusha VE; Chipens GI
    Biokhimiia; 1976 Jul; 41(6):1008-13. PubMed ID: 194624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study.
    Pérodin J; Bouley R; Escher E; Assimomytis N; Magafa V; Manessi-Zoupa E; Theodoropoulos D; Cordopatis P
    Arzneimittelforschung; 2000 Jun; 50(6):526-9. PubMed ID: 10918944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Offset of actions of angiotensin II, angiotensin III, and their analogue antagonists in renal and femoral vascular beds: further evidence for different vascular angiotensin receptors.
    Caldicott WJ; Hollenberg NK
    Life Sci; 1979 Feb; 24(6):503-12. PubMed ID: 219313
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative receptor-binding properties of heptapeptide and octapeptide antagonists of angiotensin II in rat adrenal glomerulosa and uterine smooth muscle.
    Douglas JG; Michailov M; Khosla MC; Bumpus FM
    Endocrinology; 1980 Jan; 106(1):120-4. PubMed ID: 7349950
    [No Abstract]   [Full Text] [Related]  

  • 33. Brain receptor binding and central actions of angiotensin analogs in rats.
    Mann JF; Schiller PW; Schiffrin EL; Boucher R; Genest J
    Am J Physiol; 1981 Sep; 241(3):R124-9. PubMed ID: 6269440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide antagonists of angiotensin-induced adrenal catecholamine release.
    Ackerly JA; Sarstedt CA; Peach MJ
    Eur J Pharmacol; 1977 Apr; 42(4):391-401. PubMed ID: 856615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demonstration of specific receptors for angiotensin III in rat adrenal glands].
    Devynck MA; Pernollet MG; Matthews PG; Meyer P
    C R Acad Hebd Seances Acad Sci D; 1977 Apr; 284(14):1293-6. PubMed ID: 193653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin III: (DES-Aspartic Acid-1)-Angiotensin II. Evidence and speculation for its role as an important agonist in the renin - angiotensin system.
    Goodfriend TL; Peach MJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):38-48. PubMed ID: 1132082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of angiotensin II receptors of isolated rat glomeruli: factors influencing binding affinity and comparative binding of angiotensin analogs.
    Brown GP; Douglas JG; Krontiris-Litowitz J
    Endocrinology; 1980 Jun; 106(6):1923-9. PubMed ID: 6245857
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific inhibition of receptors for angiotensin II and angiotensin III in adrenal glomerulosa.
    Simpson RU; Campanile CP; Goodfriend TL
    Biochem Pharmacol; 1980 Mar; 29(6):927-33. PubMed ID: 6248071
    [No Abstract]   [Full Text] [Related]  

  • 39. Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs.
    Krishnan R; Hanesworth JM; Wright JW; Harding JW
    Peptides; 1999; 20(8):915-20. PubMed ID: 10503768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation.
    Blumberg AL; Nishikawa K; Denny SE; Marshall GR; Needleman P
    Circ Res; 1977 Aug; 41(2):154-8. PubMed ID: 194728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.